<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>小药说药 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-11T07:25:31+08:00</updated>
  <subtitle>姓药的来说药，带你进入最深层次的医药领域，把握医药动态，了解最新前沿！</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>蓦然回首，灯火阑珊处</title>
    <updated>2020-12-11T06:03:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-11:/s/kudDWj36r5lzl3KINTYeeQ</id>
    <link href="https://mp.weixin.qq.com/s/kudDWj36r5lzl3KINTYeeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-T的中国力量</title>
    <updated>2020-12-09T06:49:23+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-09:/s/ULQJgPNddXe7ZVn1FwQpeA</id>
    <link href="https://mp.weixin.qq.com/s/ULQJgPNddXe7ZVn1FwQpeA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CAR-T克服抑制性肿瘤微环境的策略</title>
    <updated>2020-12-07T06:35:25+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-07:/s/jwitEt3Ifrs948e80VARtw</id>
    <link href="https://mp.weixin.qq.com/s/jwitEt3Ifrs948e80VARtw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>MET靶点竞争激烈，单抗、双抗、ADC如何花式突围？</title>
    <updated>2020-12-05T06:37:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-05:/s/xcMVPB0DzznABZJymMYrcA</id>
    <link href="https://mp.weixin.qq.com/s/xcMVPB0DzznABZJymMYrcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶向GPCR受体复合物：药物发现的新方向</title>
    <updated>2020-12-03T06:15:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-03:/s/C1JezF-sr4PmVB0_hhNTaw</id>
    <link href="https://mp.weixin.qq.com/s/C1JezF-sr4PmVB0_hhNTaw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>IgG4重链改造专利简述</title>
    <updated>2020-12-01T05:59:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-01:/s/QNZFklThik0uyEY9Mus5zg</id>
    <link href="https://mp.weixin.qq.com/s/QNZFklThik0uyEY9Mus5zg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>细胞疗法的潜在替代者，工程化胞外体破茧而出</title>
    <updated>2020-11-29T06:13:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-29:/s/F4urWxLBt4NJk7LAVvPgjg</id>
    <link href="https://mp.weixin.qq.com/s/F4urWxLBt4NJk7LAVvPgjg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>抗体肿瘤治疗的亚型选择</title>
    <updated>2020-11-27T06:15:16+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-27:/s/t5hCHenz98FfV2skU-JvXQ</id>
    <link href="https://mp.weixin.qq.com/s/t5hCHenz98FfV2skU-JvXQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>血脂异常治疗的新动向</title>
    <updated>2020-11-25T06:13:06+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-25:/s/nxaMNz7VKvP--KTk-yGpvQ</id>
    <link href="https://mp.weixin.qq.com/s/nxaMNz7VKvP--KTk-yGpvQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>1+1&gt;2——基因/细胞治疗开创药物新时代</title>
    <updated>2020-11-23T06:51:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-23:/s/7-0KVwgz338Q_XvOtOq_9A</id>
    <link href="https://mp.weixin.qq.com/s/7-0KVwgz338Q_XvOtOq_9A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>